CastleVax Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults (NCT07215520) | CastleVax Inc. | 2025-11-03 |
Track CastleVax Inc. automatically
Every clearance here is in the API, with alerts when new ones post.